Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen
The Korean Journal of Gastroenterology · 2024
DOI: 10.4166/kjg.2024.012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Korean Journal of Gastroenterology, 2024. Verfasst von Seyed Mohammad Valizadeh Toosi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Amoxicillin, Anti-Bacterial Agents, Clarithromycin, Drug Therapy, Combination. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Mazandaran University of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
- Medicine faculty, Mazandaran University of Medical Sciences, Sari, Iran.
ORCID-Profile: Seyed Mohammad Valizadeh Toosi
Förderung
- Mazandaran University of Medical Sciences
Zitieren
APA
Valizadeh Toosi, S. M., Feyzi, S., & Kazemi, A. (2024). Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen. The Korean Journal of Gastroenterology. https://doi.org/10.4166/kjg.2024.012
Vancouver
Valizadeh Toosi SM, Feyzi S, Kazemi A. Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen. The Korean Journal of Gastroenterology. 2024. doi:10.4166/kjg.2024.012
BibTeX
@article{ValizadehToosi2024,
author = {Valizadeh Toosi, Seyed Mohammad and Feyzi, Sahar and Kazemi, Arash},
title = {Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen},
journal = {The Korean Journal of Gastroenterology},
year = {2024},
doi = {10.4166/kjg.2024.012}
}
EUVIMED